FDA approves antiviral drug remdesivir as coronavirus treatment

Published



The Food and Drug Administration granted approval of remdesivir, an antiviral drug from Gilead Sciences and a treatment for COVID-19.

The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients, Gilead said. It is the first coronavirus disease treatment to receive FDA approval.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.